Stephan Heo, MD
Cardiovascular Disease · Manchester, NHNPI 1881822559
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (51.3%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. Shockwave Medical, Inc accounts for 80.9% of it on its own, with 23 other manufacturers making up the rest. Among cardiovascular disease clinicians in NH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 268 payments — averaging $434.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Shockwave Medical, Inc$94K
- Abbott$7K
- Medtronic$4K
- Cardinal Health 200 LLC$2K
- Biotronik Inc.$2K
- Abiomed$2K
- plus $5K from 18 others
Across 9 payments — averaging $6756.74 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- M.a. Med Alliance S.A.$61K
What the payments were for
- Consulting fees$34,97530%
- Speaking & faculty fees$59,72551%
- Travel & lodging$8,8438%
- Food & beverage$12,30711%
- Education$960%
- Gifts$5300%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Shockwave Medical, Inc | 71 | $94,207 |
| Abbott | 21 | $6,949 |
| Medtronic(2 entities) | 61 | $3,919 |
| Cardinal Health 200 LLC | 3 | $2,486 |
| Biotronik Inc. | 8 | $1,814 |
| Abiomed | 10 | $1,790 |
| Inari Medical, Inc. | 26 | $1,546 |
| Stryker | 18 | $1,179 |
| Edwards Lifesciences | 6 | $661 |
| Penumbra, Inc. | 3 | $350 |
| Cordis US CORP. | 5 | $262 |
| Boston Scientific | 4 | $236 |
| Endotronix, Inc. | 2 | $193 |
| Philips North America LLC | 2 | $154 |
| Opsens Inc. | 6 | $147 |
| Novartis | 5 | $135 |
| Chiesi USA, Inc. | 3 | $120 |
| Johnson & Johnson | 3 | $107 |
| Cardiovascular Systems Inc. | 3 | $69 |
| Pfizer | 2 | $53 |
| EKOS Corporation | 2 | $36 |
| Siemens Medical Solutions USA, Inc. | 2 | $29 |
| Cardiva Medical, Inc. | 1 | $19 |
| AstraZeneca | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$83,142
- Vascular Lithotripsy$10,757
- DRAGONFLY OPSTAR$3,500
- XIENCE XPEDITION$2,700
- FLOWTRIEVER CATHETER, S$1,645
- CT THROMBECTOMY SYSTEM KIT$1,645
- Impella$1,453
- VenaSeal$1,109
- SYMPLICITY G3$575
- COREVALVE EVOLUT R$572
- Edwards SAPIEN 3 Transcatheter Heart Valve$348
- Orsiro Mission$327
- MitraClip$280
- Indigo System$255
- CORDELLA PULOMONARY ARTERY PRESSURE SENSOR$168
- FlowTriever$161
- S.M.A.R.T. CONTROL$118
- KENGREAL$116
- PK Papyrus$106
- Pulsar$106
How this compares
$116,475 in reported general payments places this provider in the 95th percentile of 112 cardiovascular disease providers in New Hampshire.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 86 | $119,638 |
| EntrestoSacubitril/Valsartan | 27 | $44,510 |
| XareltoRivaroxaban | 14 | $21,017 |
| BrilintaTicagrelor | 12 | $5,349 |
| Metoprolol Succinate | 241 | $2,768 |
| Atorvastatin Calcium | 179 | $2,147 |
| Rosuvastatin Calcium | 117 | $1,140 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 74 | $949 |
| Losartan Potassium | 71 | $739 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 28 | $678 |
| Amlodipine Besylate | 100 | $666 |
| Pantoprazole Sodium | 43 | $663 |
| ClopidogrelClopidogrel Bisulfate | 48 | $416 |
| SotalolSotalol Hcl | 15 | $401 |
| Carvedilol | 25 | $400 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $53 | $119,63886 claims |
| NovartisEntresto | $135 | $44,51027 claims |
| Johnson & JohnsonXarelto | $107 | $21,01714 claims |
| AstraZenecaBrilinta | $17 | $5,34912 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 112 cardiovascular disease providers in New Hampshire.
Other cardiovascular disease in Manchester
- Fahad GilaniManchester$418K
- Robert CapodilupoManchester$85K
- Jeanney LewManchester$36K
- Jinu JohnManchester$12K
- Michelle OuelletteManchester$7K
- Patrick HickleManchester$5K
- Jeffrey BleakleyManchester$5K
- Tong ZhuManchester$4K
- Alan GarstkaManchester$3K
- Stephen HanlonManchester$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.